candoxatrilat has been researched along with adrenomedullin in 1 studies
| Studies (candoxatrilat) | Trials (candoxatrilat) | Recent Studies (post-2010) (candoxatrilat) | Studies (adrenomedullin) | Trials (adrenomedullin) | Recent Studies (post-2010) (adrenomedullin) |
|---|---|---|---|---|---|
| 46 | 10 | 1 | 3,135 | 131 | 1,046 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barclay, PT; Burnett, JC; Chen, HH; Jougasaki, M; Lisy, O; Schirger, JA | 1 |
1 other study(ies) available for candoxatrilat and adrenomedullin
| Article | Year |
|---|---|
Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin.
Topics: Adrenomedullin; Animals; Blood Flow Velocity; Cyclic AMP; Cyclic GMP; Cyclohexanecarboxylic Acids; Diuresis; Dogs; Glomerular Filtration Rate; Kidney; Male; Natriuresis; Neprilysin; Peptides; Protease Inhibitors; Vascular Resistance; Vasodilator Agents | 1998 |